Incidência (novos casos), taxas de incidência (por ... Nasofaringe 19 0.6 0.0 0.0 2.4 0.0 0.0 0.0 page 1

Incidência (novos casos), taxas de incidência (por ... Nasofaringe 19 0.6 0.0 0.0 2.4 0.0 0.0 0.0

  • View
    212

  • Download
    0

Embed Size (px)

Text of Incidência (novos casos), taxas de incidência (por ... Nasofaringe 19 0.6 0.0 0.0 2.4 0.0 0.0 0.0

ICD-10Novos

Casos% [0-4] [5-9] [10-14] [15-19] [20-24] [25-29] [30-34] [35-39] [40-44] [45-49] [50-54] [55-59] [60-64] [65-69] [70-74] [75-79] [80-84] [85+ Anual Europeia Mundial

0-64

(%)

0-74

(%)

C00 Lbio 48 1.5 0.0 0.0 0.0 0.0 0.0 0.0 7.7 6.3 4.5 4.5 15.6 18.2 16.1 15.0 17.9 51.9 91.7 22.5 7.9 7.9 5.4 0.4 0.5

C01-02 Lngua 44 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.5 2.3 31.3 27.3 36.2 20.0 17.9 0.0 13.1 22.5 7.2 8.1 5.9 0.5 0.7

C03-06 Boca 43 1.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.1 8.9 2.3 33.9 15.2 20.1 35.0 23.9 14.8 0.0 0.0 7.1 7.8 5.8 0.4 0.7

C07-08 Glndulas Salivares 6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.6 0.0 4.0 5.0 11.9 0.0 0.0 0.0 1.0 1.1 0.8 0.0 0.1

C09 Amgdala 32 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 20.9 30.4 28.2 10.0 6.0 0.0 0.0 0.0 5.3 5.9 4.3 0.4 0.5

C10 Orofaringe - Outros 12 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 2.6 12.1 16.1 0.0 0.0 7.4 0.0 0.0 2.0 2.2 1.6 0.2 0.2

C11 Nasofaringe 19 0.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.1 2.2 9.1 10.4 6.1 8.0 10.0 6.0 7.4 0.0 0.0 3.1 3.3 2.6 0.2 0.3

C12-13 Hipofaringe 34 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.1 15.6 36.4 24.1 15.0 6.0 7.4 0.0 0.0 5.6 6.2 4.5 0.4 0.5

C14 Faringe - Outros 5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.3 0.0 3.0 0.0 5.0 0.0 7.4 0.0 0.0 0.8 0.8 0.6 0.0 0.1

C15 Esfago 55 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.5 9.1 26.1 36.4 16.1 39.9 29.8 44.4 26.2 22.5 9.1 9.8 6.8 0.5 0.8

C16 Estmago 160 5.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 10.5 31.3 27.2 33.9 36.4 80.5 139.8 107.4 140.8 91.7 224.9 26.3 28.5 20.1 1.1 2.4

C17 Intestino Delgado 8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.3 2.6 6.1 4.0 0.0 6.0 0.0 13.1 0.0 1.3 1.4 1.0 0.1 0.1

C18-20 Clon e Recto 270 8.7 0.0 0.0 0.0 2.3 0.0 3.9 3.9 4.2 17.9 20.4 65.2 91.1 124.7 204.7 280.3 296.3 275.1 247.4 44.4 47.7 32.5 1.7 4.1

C21 nus e Canal Anal 4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 6.1 0.0 0.0 0.0 7.4 0.0 0.0 0.7 0.7 0.5 0.0 0.0

C22 Fgado 45 1.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.1 18.2 12.1 28.2 20.0 59.6 29.6 26.2 22.5 7.4 8.1 5.9 0.4 0.8

C23-24 Vescula e Tracto Biliar 38 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 4.5 2.6 9.1 12.1 20.0 41.8 37.0 78.6 134.9 6.3 6.7 4.2 0.2 0.5

C25 Pncreas 75 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.2 6.8 15.6 42.5 48.3 35.0 77.5 59.3 91.7 67.5 12.3 13.3 9.1 0.6 1.2

C30-31 Fossa Nasal e Ouvido 8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 2.3 0.0 6.1 0.0 5.0 6.0 7.4 13.1 0.0 1.3 1.3 0.9 0.1 0.1

C32 Laringe 121 3.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.1 8.9 36.2 49.5 78.9 56.3 99.9 83.5 29.6 26.2 0.0 19.9 21.8 15.9 1.2 2.1

C33-34 Traqueia, Brnquios e Pulmo 555 17.9 0.0 0.0 0.0 0.0 0.0 1.9 0.0 8.4 17.9 65.7 122.5 221.6 325.9 464.4 578.6 474.1 497.8 449.7 91.3 99.6 68.7 3.8 9.0

C37-38 rgos Torcicos - Outros 4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 8.0 5.0 0.0 0.0 0.0 0.0 0.7 0.8 0.6 0.1 0.1

C40-41 Ossos e Cartilagens 7 0.2 0.0 0.0 2.4 0.0 2.0 0.0 1.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 1.2 1.1 0.9 0.1 0.1

C43 Melanoma da Pele 48 1.5 0.0 0.0 0.0 2.3 4.1 3.9 7.7 10.5 8.9 2.3 2.6 15.2 20.1 39.9 17.9 29.6 26.2 22.5 7.9 8.1 6.2 0.4 0.7

C44 Pele no Melanoma 637 20.5 0.0 0.0 0.0 0.0 0.0 5.8 11.6 25.3 38.0 65.7 93.8 118.4 281.7 429.4 656.1 763.0 943.1 1191.8 104.8 111.6 74.0 3.2 8.6

C45 Mesotelioma 1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.2 0.1 0.1 0.0 0.0

C46 Sarcoma de Kaposi 5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.2 0.0 0.0 0.0 4.0 0.0 0.0 7.4 0.0 22.5 0.8 0.9 0.6 0.0 0.0

C47+C49 Tec. Conjuntivo e Tecidos Moles 15 0.5 5.5 2.6 0.0 0.0 2.0 0.0 0.0 0.0 2.2 2.3 0.0 6.1 0.0 15.0 6.0 7.4 0.0 45.0 2.5 2.8 2.5 0.1 0.2

C50 Mama 8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 10.0 6.0 0.0 26.2 45.0 1.3 1.5 0.9 0.0 0.1

C60 Pnis 8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.2 0.0 0.0 0.0 8.0 15.0 0.0 7.4 0.0 0.0 1.3 1.5 1.1 0.1 0.1

C61 Prstata 697 22.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 34.0 86.0 215.6 382.2 669.1 823.1 844.5 812.2 764.6 114.7 124.7 83.3 3.6 11.1

C62 Testculo 36 1.2 0.0 0.0 0.0 4.5 12.3 17.4 13.5 8.4 4.5 4.5 7.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 5.3 5.2 0.4 0.4

C63 Ap. Genital Masculino - Outros 3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 5.0 0.0 7.4 0.0 0.0 0.5 0.5 0.4 0.0 0.0

C64 Rim 70 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 4.5 6.8 13.0 36.4 20.1 69.9 41.8 88.9 52.4 45.0 11.5 12.3 8.4 0.5 1.0

C65 Plvis Renal 8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.0 4.0 5.0 0.0 7.4 26.2 0.0 1.3 1.4 0.9 0.1 0.1

C66 Ureter 3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 6.0 7.4 0.0 0.0 0.5 0.5 0.3 0.0 0.1

C67 Bexiga 179 5.8 0.0 0.0 0.0 0.0 2.0 1.9 0.0 4.2 11.2 6.8 20.9 54.7 60.4 129.8 101.4 318.5 248.9 472.2 29.5 31.4 20.0 0.8 2.0

C68 Aparelho Urinrio - Outros 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

C69 Olhos e Anexos Oculares 7 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.3 0.0 0.0 8.0 0.0 6.0 0.0 13.1 0.0 1.2 1.2 1.1 0.1 0.1

C70-72 Crebro e SNC 43 1.4 0.0 2.6 2.4 2.3 2.0 1.9 1.9 4.2 4.5 4.5 2.6 12.1 28.2 10.0 23.9 51.9 78.6 0.0 7.1 7.1 5.3 0.4 0.5

C73 Tiride 10 0.3 0.0 0.0 0.0 2.3 2.0 1.9 1.9 4.2 2.2 2.3 0.0 0.0 4.0 0.0 0.0 7.4 0.0 0.0 1.7 1.5 1.4 0.1 0.1

C74 Supra Renal 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

C75 Outras Glndulas Endcrinas 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

C81 Linfoma de Hodgkin 27 0.9 0.0 0.0 4.9 2.3 10.2 3.9 1.9 6.3 6.7 4.5 5.2 6.1 4.0 0.0 0.0 7.4 13.1 22.5 4.4 4.3 3.9 0.3 0.3

C82-85, C96 Linfoma no Hodgkin 115 3.7 0.0 0.0 4.9 2.3 0.0 5.8 7.7 4.2 20.1 24.9 20.9 30.4 44.3 59.9 95.4 88.9 104.8 134.9 18.9 19.8 14.3 0.8 1.6

C88 Doenas Imunoproliferativas 2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.3 0.3 0.1 0.0 0.0

C90 Mieloma Mltiplo 29 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.1 2.2 0.0 2.6 9.1 20.1 20.0 23.9 22.2 65.5 22.5 4.8 5.0 3.4 0.2 0.4

C91 Leucemia Linfide 28 0.9 5.5 0.0 2.4 2.3 2.0 0.0 0.0 0.0 0.0 2.3 0.0 15.2 4.0 35.0 17.9 14.8 13.1 67.5 4.6 5.2 4.1 0.2 0.4

C92-94 Leucemia Mielide 24 0.8 0.0 0.0 0.0 2.3 2.0 1.9 0.0 4.2 4.5 0.0 2.6 9.1 8.0 5.0 23.9 0.0 39.3 67.5 4.0 4.2 3.0 0.2 0.3

C95 Leucemia SOE 4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.7 0.6 0.3 0.0 0.0

D45+D47 D. Mieloproliferativas Crnicas 19 0.6 2.8 0.0 0.0 0.0 2.0 0.0 3.9 0.0 2.2 2.3 0.0 6.1 4.0 20.0 17.9 22.2 0.0 0.0 3.1 3.3 2.6 0.1 0.3

D46 Sndromes Mielodisplsicos 26 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 6.1 8.0 30.0 11.9 29.6 52.4 45.0 4.3 4.6 3.0 0.1 0.3

O&U Outros e Localizaes mal Definidas 100 3.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 2.1 4.5 11.3 23.5 42.5 48.3 49.9 71.6 133.3 131.0 134.9 16.5 17.5 11.7 0.7 1.3

Total 3745 120.5 19.3 7.7 21.8 22.7 43.0 52.2 75.4 134.9 241.4 407.5 769.0 1287.4 1822.7 2766.4 3310.5 3733.6 3916.7 4317.5 616.2 661.4 457.0 24.5 54.9

Total excepto C44 3108 100 19.3 7.7 21.8 22.7 43.0 46.4 63.8 109.6 203.4 341.8 675.1 1169.0 1541.1 2337.0 2654.3 2970.6 2973.5 3125.7 511.4 549.7 382.9 21.3 46.3

Incidncia (novos casos), taxas de incidncia (por 100000) e riscos cumulativos (%) do cancro - Homens

Regio Autnoma dos Aores 2007-2011